Zobrazeno 1 - 10
of 250
pro vyhledávání: '"Richard, Quinton"'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/84fe9085ba804594a12698c7cbf0a5c4
Autor:
Moira Cruickshank, Jemma Hudson, Rodolfo Hernández, Magaly Aceves-Martins, Richard Quinton, Katie Gillies, Lorna S Aucott, Charlotte Kennedy, Paul Manson, Nicholas Oliver, Frederick Wu, Siladitya Bhattacharya, Waljit S Dhillo, Channa N Jayasena, Miriam Brazzelli
Publikováno v:
Health Technology Assessment, Vol 28, Iss 43 (2024)
Background Low levels of testosterone cause male hypogonadism, which is associated with sexual dysfunction, tiredness and reduced muscle strength and quality of life. Testosterone replacement therapy is commonly used for ameliorating symptoms of male
Externí odkaz:
https://doaj.org/article/411d8148060c4170829abab78f1ee422
Autor:
Bonnie Grant, Joseph Kean, Naim Vali, John Campbell, Lorraine Maden, Prun Bijral, Waljit S. Dhillo, James McVeigh, Richard Quinton, Channa N. Jayasena
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Anabolic–androgenic steroids (AAS) mimic the effects of testosterone and may include testosterone itself; they are used for body enhancement within the general population. AAS use has been linked with increased mortality, cardio
Externí odkaz:
https://doaj.org/article/019245d9c84f48bf9d7fcf26ce9754c4
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/7b299d1e76334a0ea184cc3b1d3b364b
Autor:
Bonnie Grant, Anjali Pradeep, Suks Minhas, Waljit S Dhillo, Richard Quinton, Channa N Jayasena
Publikováno v:
Reproduction and Fertility, Vol 4, Iss 1, Pp 1-3 (2023)
Anabolic steroids (also known as ‘steroids’) are banned drugs like testosterone, which make muscles bigger in men. These drugs are dangerous because they stop the testes from making natural testosterone and can cause heart attacks. Men stopping s
Externí odkaz:
https://doaj.org/article/7dcff48a3f3843178bf74459511066ac
Autor:
Valeria Vezzoli, Faris Hrvat, Giovanni Goggi, Silvia Federici, Biagio Cangiano, Richard Quinton, Luca Persani, Marco Bonomi
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2023)
Distinguishing between self limited delayed puberty (SLDP) and congenital hypogonadotropic hypogonadism (CHH) may be tricky as they share clinical and biochemical characteristics. and appear to lie within the same clinical spectrum. However, one is c
Externí odkaz:
https://doaj.org/article/37c178981d3540e982414cca9cd996bf
Autor:
Ali Abbara, Kanyada Koysombat, Maria Phylactou, Pei Chia Eng, Sophie Clarke, Alexander N. Comninos, Lisa Yang, Chioma Izzi-Engbeaya, Simon Hanassab, Neil Smith, Channa N. Jayasena, Cheng Xu, Richard Quinton, Nelly Pitteloud, Gerhard Binder, Ravinder Anand-Ivell, Richard Ivell, Waljit S. Dhillo
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundDelayed puberty in males is almost invariably associated with constitutional delay of growth and puberty (CDGP) or congenital hypogonadotrophic hypogonadism (CHH). Establishing the cause at presentation is challenging, with “red flag” f
Externí odkaz:
https://doaj.org/article/65865504228c43389686a6059514ae8a
Autor:
Luca Giovanelli, Richard Quinton, Biagio Cangiano, Stefano Colombo, Luca Persani, Marco Bonomi, Iacopo Chiodini
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveExperimental studies proposed a direct effect of follicle-stimulating hormone (FSH) on the skeletal metabolism, but results of human studies mainly conducted in females are controversial. The present study aims to investigate the possible ro
Externí odkaz:
https://doaj.org/article/755e2cd9115c4880b08e1464342205dc
Autor:
Jemma Hudson, MSc, Moira Cruickshank, PhD, Richard Quinton, MD, Lorna Aucott, PhD, Magaly Aceves-Martins, PhD, Katie Gillies, PhD, Shalender Bhasin, ProfMB BS, Peter J Snyder, ProfMD, Susan S Ellenberg, ProfPhD, Mathis Grossmann, ProfPhD, Thomas G Travison, PhD, Emily J Gianatti, PhD, Yvonne T van der Schouw, ProfPhD, Marielle H Emmelot-Vonk, ProfPhD, Erik J Giltay, PhD, Geoff Hackett, FRCPI, Sudarshan Ramachandran, PhD, Johan Svartberg, ProfPhD, Kerry L Hildreth, MD, Kristina Groti Antonic, PhD, Gerald B Brock, ProfMD, J Lisa Tenover, ProfMD, Hui Meng Tan, FRCS, Christopher Ho Chee Kong, FRCS, Wei Shen Tan, PhD, Leonard S Marks, ProfMD, Richard J Ross, ProfMD, Robert S Schwartz, ProfMD, Paul Manson, BA Hons, Stephen Roberts, PhD, Marianne Skovsager Andersen, ProfDmSci, Line Velling Magnussen, PhD, Rodolfo Hernández, PhD, Nick Oliver, ProfFRCP, Frederick Wu, ProfMD, Waljit S Dhillo, ProfPhD, Siladitya Bhattacharya, ProfMD, Miriam Brazzelli, PhD, Channa N Jayasena, PhD
Publikováno v:
The Lancet. Healthy Longevity, Vol 3, Iss 6, Pp e381-e393 (2022)
Summary: Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide the most extensive individual participant dataset (IPD) of t
Externí odkaz:
https://doaj.org/article/70b4dbf3d7d14292b6edc7c0fd36828c
Autor:
Ahmed Al-Sharefi, Richard Quinton
Publikováno v:
Endocrinology and Metabolism, Vol 35, Iss 3, Pp 526-540 (2020)
Male hypogonadism—rebadged by some as testosterone deficiency syndrome—is a clinical and biochemical diagnosis of increasing worldwide interest. Organic male hypogonadism—usually permanent—is well-established, but aging men may also exhibit l
Externí odkaz:
https://doaj.org/article/d38fc64776c8447396aee5321f75b374